Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study

dc.authorid0000-0002-5880-6352
dc.authorid0000-0002-2093-7787
dc.authorid0000-0001-8475-398X
dc.authorid0000-0003-3595-9759
dc.authorid0000-0001-9473-2920
dc.authorid0000-0002-7347-7761
dc.authorid0000-0001-7422-7169
dc.contributor.authorJudge, Conor
dc.contributor.authorO'Donnell, Martin J.
dc.contributor.authorHankey, Graeme J.
dc.contributor.authorRangarajan, Sumathy
dc.contributor.authorChin, Siu Lim
dc.contributor.authorRao-Melacini, Purnima
dc.contributor.authorFerguson, John
dc.date.accessioned2025-05-10T19:38:39Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBACKGROUND Although low sodium intake (<2 g/day) and high potassium intake (>3.5 g/day) are proposed as public health interventions to reduce stroke risk, there is uncertainty about the benefit and feasibility of this combined recommendation on prevention of stroke. METHODS We obtained random urine samples from 9,275 cases of acute first stroke and 9,726 matched controls from 27 countries and estimated the 24-hour sodium and potassium excretion, a surrogate for intake, using the Tanaka formula. Using multivariable conditional logistic regression, we determined the associations of estimated 24-hour urinary sodium and potassium excretion with stroke and its subtypes. RESULTS Compared with an estimated urinary sodium excretion of 2.8-3.5 g/ day (reference), higher (>4.26 g/day) (odds ratio [OR] 1.81; 95% confidence interval [CI], 1.65-2.00) and lower (<2.8 g/day) sodium excretion (OR 1.39; 95% CI, 1.26-1.53) were significantly associated with increased risk of stroke. The stroke risk associated with the highest quartile of sodium intake (sodium excretion >4.26 g/day) was significantly greater (P < 0.001) for intracerebral hemorrhage (ICH) (OR 2.38; 95% CI, 1.93-2.92) than for ischemic stroke (OR 1.67; 95% CI, 1.50-1.87). Urinary potassium was inversely and linearly associated with risk of stroke, and stronger for ischemic stroke than ICH (P = 0.026). In an analysis of combined sodium and potassium excretion, the combination of high potassium intake (>1.58 g/day) and moderate sodium intake (2.8-3.5 g/day) was associated with the lowest risk of stroke. CONCLUSIONS The association of sodium intake and stroke is J-shaped, with high sodium intake a stronger risk factor for ICH than ischemic stroke. Our data suggest that moderate sodium intake-rather than low sodium intake-combined with high potassium intake may be associated with the lowest risk of stroke and expected to be a more feasible combined dietary target.
dc.description.sponsorshipCanadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canadian Stroke Network; Swedish Research Council; Swedish Heart and Lung Foundation; Health & Medical Care Committee of the Regional Executive Board; Astra Zeneca; Boehringer Ingelheim (Canada); Pfizer (Canada); MERCK; Sharp and Dohme; UK Heart and Stroke; Wellcome TrustHealth Research Board Irish Clinical Academic Training (ICAT); European Research Council COSIP Grant [640580]; Region Vastra Gotaland; UK Chest; European Research Council (ERC) [640580] Funding Source: European Research Council (ERC)
dc.description.sponsorshipThe INTERSTROKE study is funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, The Health & Medical Care Committee of the Regional Executive Board, Region Vastra Gotaland, and through unrestricted grants from several pharmaceutical companies with major contributions from Astra Zeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MERCK, Sharp and Dohme, Swedish Heart and Lung Foundation, UK Chest, and UK Heart and Stroke. C.J. was funded by Wellcome TrustHealth Research Board Irish Clinical Academic Training (ICAT). M.O.D. was funded by European Research Council COSIP Grant 640580.
dc.identifier.doi10.1093/ajh/hpaa176
dc.identifier.endpage425
dc.identifier.issn0895-7061
dc.identifier.issn1941-7225
dc.identifier.issue4
dc.identifier.pmid33197265
dc.identifier.scopus2-s2.0-85105696305
dc.identifier.scopusqualityQ1
dc.identifier.startpage414
dc.identifier.urihttps://doi.org/10.1093/ajh/hpaa176
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9421
dc.identifier.volume34
dc.identifier.wosWOS:000672271200019
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofAmerican Journal of Hypertension
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectblood pressure
dc.subjecthypertension
dc.subjectintracerebral hemorrhage
dc.subjectischemic stroke
dc.subjectpotassium
dc.subjectsodium
dc.subjectstroke
dc.titleUrinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9421.pdf
Boyut:
984.98 KB
Biçim:
Adobe Portable Document Format